MindBio Therapeutics Corp., a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, has expanded its artificial intelligence-based platform with the rollout of Intox Collect. This new software tool is designed to broaden the company's data collection and analytics capabilities across a wider range of substances that affect the central nervous system.
The Intox Collect technology enhances the company's ability to collect and analyze voice and facial recognition data tied to drug and alcohol impairment. According to the company, the platform broadens detection capabilities beyond alcohol to include multiple central nervous system stimulants and depressants. This expansion represents a significant development in workplace safety technology, particularly for industries where intoxication poses serious risks.
MindBio's AI model currently uses more than 50 million data points, with management expecting that figure to increase further as the Intox Collect system gathers additional information. The company is developing Edge AI kiosk hardware for enterprise deployment, with prototype testing expected in the second quarter of 2026. This hardware development suggests a move toward more integrated, on-site testing solutions that could be deployed directly in workplace environments.
Target industries for this technology include mining, aviation, construction, law enforcement, and any environments where intoxication testing is frequently required for safety and compliance. The broader detection capabilities offered by Intox Collect could potentially address substance abuse issues beyond alcohol, which has been the traditional focus of workplace intoxication testing. The latest news and updates relating to the company are available in its newsroom at https://ibn.fm/MBQIF.
The development of this expanded platform comes at a time when workplace safety regulations are becoming increasingly stringent across multiple industries. By moving beyond alcohol detection to include other central nervous system affecting substances, MindBio's technology could provide employers with more comprehensive tools for maintaining safe work environments. The company's focus on voice and facial recognition data represents a non-invasive approach to intoxication detection that could potentially be integrated into routine workplace procedures without disrupting operations.
